Abstract
At the cellular level, expansion of haemopoiesis in chronic myeloid leukaemia (CML) must involve some imbalance in cell production along the myeloid maturation pathway. The relevant kinetic parameters are cell loss by apoptosis and differentiation and cell gain by proliferation (self-renewal). In spite of the predominance of the BCR-ABL-positive leukaemic cells, some BCR-ABL-negative, presumably normal, progenitor cells remain for long periods in chronic phase CML. Thus, understanding the kinetics of CML and normal progenitor cells may lead to therapeutic strategies capable of reducing malignant cell growth and reactivating normal haemopoiesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gordon, M., Dazzi, F., Marley, S. et al. Cell biology of CML cells. Leukemia 13 (Suppl 1), S65–S71 (1999). https://doi.org/10.1038/sj.leu.2401281
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401281
Keywords
This article is cited by
-
Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid Leukemia
Scientific Reports (2016)
-
A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia
Bulletin of Mathematical Biology (2011)
-
Identification of genes potentially involved in disease transformation of CML
Leukemia (2005)
-
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies
Leukemia (2003)
-
Cellular and molecular themes in apoptosis
Wiener Klinische Wochenschrift (2003)